la Notice du Vimovo
ON NE JOUE PAS DANS LA MEME CATEGORIE :-)))
Important Safety Information about VIMOVO
Cardiovascular Risk
Naproxen, a component of VIMOVO, may cause an increased risk of serious cardiovascular thrombotic events, myocardial infarction, and stroke, which can be fatal. This risk may increase with duration of use. Patients with cardiovascular disease or risk factors for cardiovascular disease may be at greater risk.
VIMOVO is contraindicated for the treatment of peri-operative pain in the setting of coronary artery bypass graft (CABG) surgery.
As with all NSAIDs, VIMOVO can lead to the onset of new hypertension or worsening of pre-existing hypertension, either of which may contribute to the increased incidence of CV events. Blood pressure should be monitored closely
lien :
http://www.prnewswire.com/news-releases/fda-approved-vimovotm-for-arthritis-patients-at-risk-of-developing-nsaid-associated-gastric-ulcers-92563369.html